1748P - Phase I open-label study evaluating the safety, pharmacokinetics, and preliminary efficacy of ABBV-181 and rovalpituzumab tesirine (ROVA-T) in patients with small cell lung cancer

Emiliano Calvo ,Y Ohe,Hans Prenen ,Daniel Afar ,Alexander I Spira ,Takashi Seto ,Sylvie Rottey ,Víctor Moreno ,Philippe Cassier ,Antoîne Italiano ,Stacie Lambert ,Stefan Englert ,Philip Komarnitsky ,Apurvasena Parikh ,Anas Gazzah ,Michael Millward ,Gregory Vosganian ,Kiyotaka Yoh ,Tuomo Alanko ,Bo Gao

doi:10.1093/annonc/mdz264.012

1748P - Phase I open-label study evaluating the safety, pharmacokinetics, and preliminary efficacy of ABBV-181 and rovalpituzumab tesirine (ROVA-T) in patients with small cell lung cancer

Emiliano Calvo , Y Ohe + Show 18 more

Open Access

https://doi.org/10.1093/annonc/mdz264.012

Copy DOI

Journal: Annals of Oncology	Publication Date: Oct 1, 2019
Citations: 1	License type: publisher-specific-oa

Affiliation: Hospital Universitario HM Sanchinarro, Antwerp University Hospital, AbbVie (United States), Virginia Cancer Specialists, National Hospital Organization Kyushu Cancer Center, Institute of Pharmacology, Hospital Universitario Fundación Jiménez Díaz, Cancer Research Center of Lyon, Institut Bergonié, AbbVie (Germany), Institut Gustave Roussy, University of Paris-Saclay, Institut Polytechnique de Paris, Linear Clinical Research, National Cancer Center Hospital East, Docrates Cancer Center, Westmead Hospital

#Research Grant #Rovalpituzumab Tesirine + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

1748P - Phase I open-label study evaluating the safety, pharmacokinetics, and preliminary efficacy of ABBV-181 and rovalpituzumab tesirine (ROVA-T) in patients with small cell lung cancer

Full Text

Paper version not known

Open DOI Link

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title

Journal

Date

Author

View more papers

More From: Annals of Oncology

Paper Title

Journal

Date

Author

View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.